Home       Market Dynamics     Macro Trends     Sector Trends     Company Insights     AI Investing     Strategies     Sign Up     Login         

Amgen (AMGN) Stock Price Prediction and News Highlight
Tue. Sep 22, 2026

One Week Return: 9.23%, One Month Return: -6.71%, Three Month Return: 18.97%

Sector: Health Care

Amgen is demonstrating strong momentum in product and service development with significant advancements in its drug pipeline and successful outcomes in recent clinical trials. The company's commitment to addressing unmet medical needs is highlighted by its successful Phase 3 trial for treatments targeting Sjögren's disease and effective progress in developing therapies for autoimmune diseases. This reflects Amgen's strategic investment in research and development and its potential for future growth. Overall, these factors position Amgen favorably in the pharmaceutical industry.

The price action of Amgen (AMGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 1 is bullish. The market sentiment at 1.4 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. AMGN is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.4, and the negative at 0 on 2026-09-22. The forces of Sentiment towards Fundamentals (3.3), Market Risk Appetite (2.3), Option Sentiment (1.5), Stock Price Trend (1), Sector Price Trend (0.3), Valuation Sentiment (0.2), and Price Level Sentiment (0) will drive up the price. The forces of and Price Level Sentiment (0) will drive down the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-11-03 01:00, EPS: $22.37, P/E: 18.33

Sign up to reveice notifications on Market Movers
AMGN
DateAttentionPriceStdDevPrice
Level
RSIHourly
RSI
Change10 Day
Trend
Trend
Sentiment
Hourly
Trend
Sentiment
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2026-09-220%(0%)      410.03 6.63%    50    38   85   4.25%    0.5% 1    0.9    2.3%    1.4    Long    55% 3.3    6   
2026-09-210%(0%)      393.33 7.19%    34    33   84   2.12%    -1.13% -1.4    0.4    1.4%    0.6    Wait    50% 1.5    -1   
2026-09-200%(0%)    -1.9    0.4    0          1.5    -1   
2026-09-190%(0%)    -1.9    0.4    0          1.5    -1   
2026-09-180%(0%)      385.17 7.43%    25    27   72   1.44%    -1.5% -1.9    0.4    0.8%    0.4    Short    65% 1.1    -1   
2026-09-170%(0%)      379.69 7.41%    18    22   62   0.9%    -1.57% -2.4    0.1    0.5%    0.3    Short    65% 1.5    -1   
2026-09-160%(0%)      376.29 7.28%    11    18   50   0.24%    -1.53% -2.5    -0.2    0.5%    0.3    Short    65% 2    -1   
2026-09-150%(0%)      375.4 6.82%    5    17   42   -1.75%    -1.34% -2.3    -0.3    0.5%    0.3    Short    70% 2.3    -1   
2026-09-140%(0%)      382.07 6.1%    5    18   60   1.09%    -1.2% -3    0.1    0.5%    -0.1    Wait    50% 0.7    -1   
2026-09-130%(0%)    -3.5    0.1    -1.3          -0.3    -1   
 
Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend.

Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.

Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2026-09-22 17:53:15 The mention of partnerships with data providers like Dow Jones suggests a collaboration that enhances market analysis and reporting capabilities.
2026-09-22 17:53:15 The article highlights the reliance on robust market data from established sources, reflecting a trend towards data-driven investment decisions.
2026-09-22 17:53:15 The article discusses Amgen Inc. stock's outperformance against competitors, indicating strong investor confidence and market positioning.
2026-09-22 17:05:19 The positive results from late-stage trials signal a more competitive landscape for treatments in autoimmune conditions.
2026-09-22 17:05:19 Analyses regarding Amgen's valuation hint at potential overvaluation, sparking discussions about its market performance.
2026-09-22 17:05:19 Recent stock price movements and evaluations indicate a strong investor interest and performance in Amgen's shares.
2026-09-22 17:05:19 Amgen's extended partnership with Veeva emphasizes the importance of collaboration in driving business growth and innovation.
2026-09-22 17:05:19 Positive outcomes in clinical trials for Amgen's drug dazodalibep indicate successful product development in addressing autoimmune diseases.
2026-09-22 15:47:07 The requirement for additional trial data before approval filing indicates potential regulatory hurdles that could delay market access for the drug.
2026-09-22 15:47:07 Amgen's successful Phase 3 trial indicates progress in the development of treatments for Sjögren's disease, showcasing the company's commitment to addressing unmet medical needs.
2026-09-22 11:47:43 There is a discrepancy between broader market perceptions and the insights gained from private discussions with Amgen management.
2026-09-22 11:47:43 Amgen is seen as having a competitive edge over its rivals in the heart-drug market after competitor setbacks.
2026-09-22 11:47:43 Morgan Stanley's positive outlook on Amgen based on their management meeting indicates strong analyst confidence in the company.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA